The FAERS Public Dashboard and its Value to the Pharmaceutical Industry
Jul 31, 2018 - 00:24:45
Radio and PodcastLive Radio & PodcastsLoading episode
Fetching episode details...
Radio and PodcastLive Radio & PodcastsRadio and PodcastLive Radio & PodcastsFetching episode details...
Radio and PodcastLive Radio & PodcastsFDA medical oncologists discuss the agency’s accelerated approval of rucaparib for treatment of patients with deleterious BRCA mutation-associated advanced ovarian cancer who have been treated with two or more chemothera...
FDA D.I.S.C.O.: Rucaparib in Ovarian Cancer is an episode from FDA Drug Information Updates by ReachMD. FDA medical oncologists discuss the agency’s accelerated approval of rucaparib for treatment of patients with deleterious BRCA mutation-...
This episode belongs to FDA Drug Information Updates.
Use the player on this page to stream the episode online.
Published May 17, 2017, 00:05:00 long, audio available.
Continue listening to more episodes from FDA Drug Information Updates.
Jul 31, 2018 - 00:24:45
May 4, 2018 - 00:02:59
Jan 7, 2018 - 00:08:29
Jan 5, 2018 - 00:02:59
Oct 29, 2017 - 00:09:22
Aug 17, 2017 - 00:05:29
Jul 28, 2017 - 00:06:00